Amicus (FOLD) Worth Up to $50/Sh in a Takeover, Chardan Says; Scioderm Deal Terms Suggest Future Sale
While not in their model, Chardan Capital Markets sees Amicus Therapeutics (NASDAQ: FOLD) worth $25-$50 in a takeover.Analyst Gbola Amus ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)